Cybin Inc. (OTCMKTS:CLXPF – Get Free Report) shares were up 5.9% during mid-day trading on Thursday . The stock traded as high as $6.43 and last traded at $6.26. Approximately 293,158 shares changed hands during trading, a decline of 47% from the average daily volume of 551,962 shares. The stock had previously closed at $5.91.
Cybin Stock Down 4.5 %
The firm has a market cap of $845.52 million and a price-to-earnings ratio of -23.71. The firm has a fifty day moving average price of $8.27 and a 200-day moving average price of $9.17.
About Cybin
Cybin Inc, a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products.
Further Reading
- Five stocks we like better than Cybin
- How to buy stock: A step-by-step guide for beginners
- Conagra Stock Could Thrive as Tariffs Hit Other Sectors
- What is the MACD Indicator and How to Use it in Your Trading
- Grocery Costs and Tariffs Now Top of Mind in Everyday Conversations, New Survey Finds
- Profitably Trade Stocks at 52-Week Highs
- Spotify Stock Eyes Double-Digit Upside—Is Now the Time to Buy?
Receive News & Ratings for Cybin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cybin and related companies with MarketBeat.com's FREE daily email newsletter.
